Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026
Dec 4, 2025DOI: 10.1056/nejmsa2514268Special ArticleNEJM
Written by: Jake Scott, M.D.Michael S. Abers, M.D.Harleen K. Marwah, M.D.Nicole C. McCann, B.A.Eric A. Meyerowitz, M.D.Aaron Richterman, M.D., M.P.H.Derek F. Fleming, Ph.D.Elise J. Holmes, M.P.P.Leah E. Moat, M.P.H.Sydney G. Redepenning, Ph.D.Emily A. Smith, Ph.D., M.P.H.Clare J. Stoddart, M.S.Maria E. Sundaram, Ph.D., M.S.P.H.Angela K. Ulrich, Ph.D., M.P.H.Christopher Alba, B.S.Cory J. Anderson, Ph.D., M.P.H.Meredith K. Arpey, M.P.H.Ethan Borre, M.D., Ph.D.Joseph Ladines-Lim, M.D., Ph.D.Angela J. Mehr, M.P.H.Katherine Rich, M.D., M.P.H.Corey Watts, M.D.Nicole E. Basta, Ph.D.Jana Jarolimova, M.D., M.P.H.Rochelle P. Walensky, M.D., M.P.H.Caitlin M. Dugdale, M.D.
Find these authors on Roon
CW
Dr. Corey Watts
Mycobacterial Disease · HUP
RW
Dr. Rochelle Walensky
General ID · Harvard Medical School
[Free Article]
Summary
Results from recently published, peer-reviewed studies support the safety and effectiveness of immunizations against Covid-19, RSV, and influenza.
CW
Dr. Corey Watts
Infectious Disease · Mycobacterial DiseaseHospital of the University of Pennsylvaniacorey